X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiac & cardiovascular systems (24) 24
humans (23) 23
index medicus (22) 22
female (19) 19
male (19) 19
aged (14) 14
clopidogrel (13) 13
treatment outcome (12) 12
middle aged (11) 11
cardiovascular (10) 10
coronary heart disease (10) 10
percutaneous coronary intervention (10) 10
time factors (10) 10
bleeding (9) 9
drug-eluting stents (9) 9
cardiac patients (8) 8
drug therapy, combination (8) 8
outcomes (8) 8
percutaneous coronary intervention - adverse effects (8) 8
platelet aggregation inhibitors - administration & dosage (8) 8
acute coronary syndrome (7) 7
aged, 80 and over (7) 7
hemorrhage - chemically induced (7) 7
mortality (7) 7
platelet aggregation inhibitors - adverse effects (7) 7
risk factors (7) 7
stents (7) 7
ticlopidine - administration & dosage (7) 7
ticlopidine - analogs & derivatives (7) 7
acute coronary syndromes (6) 6
analysis (6) 6
aspirin - administration & dosage (6) 6
coronary artery disease - therapy (6) 6
guidelines (6) 6
transluminal angioplasty (6) 6
adenosine (5) 5
cardiovascular events (5) 5
eluting stent implantation (5) 5
induced intimal hyperplasia (5) 5
metaanalysis (5) 5
percutaneous coronary intervention - methods (5) 5
thrombosis (5) 5
ticagrelor (5) 5
abridged index medicus (4) 4
acute myocardial-infarction (4) 4
cardiology (4) 4
care and treatment (4) 4
dapt (4) 4
drug administration schedule (4) 4
dual antiplatelet therapy (4) 4
dual-antiplatelet therapy (4) 4
heart attacks (4) 4
impact (4) 4
intervention (4) 4
percutaneous coronary intervention - instrumentation (4) 4
percutaneous coronary intervention - mortality (4) 4
proportional hazards models (4) 4
purinergic p2y receptor antagonists - administration & dosage (4) 4
revascularization (4) 4
risk assessment (4) 4
stents - adverse effects (4) 4
610 medicine & health (3) 3
acute coronary syndrome - therapy (3) 3
anticoagulants (3) 3
cardiology and cardiovascular medicine (3) 3
cardiovascular disease (3) 3
clinical trials (3) 3
coronary artery disease - diagnostic imaging (3) 3
coronary artery disease - mortality (3) 3
events (3) 3
heart (3) 3
high bleeding risk (3) 3
implantation (3) 3
incidence (3) 3
insights (3) 3
ischemic events (3) 3
myocardial infarction (3) 3
myocardial infarction - etiology (3) 3
myocardial-infarction (3) 3
platelet aggregation inhibitors - therapeutic use (3) 3
prasugrel (3) 3
risk (3) 3
ticlopidine - adverse effects (3) 3
trial (3) 3
zotarolimus-eluting stent (3) 3
1506 (2) 2
abciximab (2) 2
acute coronary syndrome - blood (2) 2
acute coronary syndrome - diagnostic imaging (2) 2
adenosine - administration & dosage (2) 2
adenosine - analogs & derivatives (2) 2
administration, oral (2) 2
american-college (2) 2
angiography (2) 2
angioplasty (2) 2
antiaggregants (2) 2
artery-disease (2) 2
aspirin - adverse effects (2) 2
aspirin - therapeutic use (2) 2
association task-force (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Andò, Giuseppe and Cortese, Bernardo and Russo, Filippo and Rothenbühler, Martina and Frigoli, Enrico and Gargiulo, Giuseppe and Briguori, Carlo and Vranckx, Pascal and Leonardi, Sergio and Guiducci, Vincenzo and Belloni, Flavia and Ferrari, Fabio and de la Torre Hernandez, Jose Maria and Curello, Salvatore and Liistro, Francesco and Perkan, Andrea and De Servi, Stefano and Casu, Gavino and Dellavalle, Antonio and Fischetti, Dionigi and Micari, Antonio and Loi, Bruno and Mangiacapra, Fabio and Russo, Nunzio and Tarantino, Fabio and Saia, Francesco and Heg, Dik and Windecker, Stephan and Jüni, Peter and Valgimigli, Marco and Salomone, Maria and Frigoli, Enrico and Occhilupo, Pierpaolo and Lodolini, Veronica and Monti, Monia and Mazzone, Maria Grazia and Delos, Erika and Caruso, Maria Teresa and Testa, Maggie and Ciociano, Nestor and Lazzero, Maurizio and Gazzotti, Davide and Cagliari, Lorenzo and Shahmohammadi, Leila and Caiazza, Martina and Virga, Vittorio and Guerra, Elena and Michalska, Eva and Castellini, Sara and Serino, Vincenzo and Visconti, Gabriella and Pendenza, Gianluca and Portolan, Monica and Anzini, Marco and Silvetti, Elisa and Coco, Tiziana and Costa, Francesco and Ariotti, Sara and Valli, Linda and Adamo, Marianna and Marino, Marcello and Vranckx, Pascal and Leonardi, Sergio and Tricoci, Pierluigi and Jüni, Peter and Rothenbühler, Martina and Heg, Dik and Valgimigli, Marco and Gagnor, Andrea and Calabrò, Paolo and Rubartelli, Paolo and Garducci, Stefano and Santarelli, Andrea and Galli, Mario and Garbo, Roberto and Bramucci, Ezio and Ierna, Salvatore and Briguori, Carlo and Cortese, Bernardo and Limbruno, Ugo and Violini, Roberto and Presbitero, Patrizia and de Cesare, Nicoletta and Sganzerla, Paolo and Ausiello, Arturo and Tosi, Paolo and Sardella, Gennaro and Sabate, Manel and Brugaletta, Salvatore and Saccone, Giovanni and Vandoni, Pietro and Zingarelli, Antonio and Liso, Armando and Rigattieri, Stefano and Di Lorenzo, Emilio and Vigna, Carlo and Palmieri, Cataldo and Falcone, Camillo and De Caterina, Raffaele and Caputo, Marcello and ... and MATRIX Investigators
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2017, Volume 69, Issue 21, pp. 2592 - 2603
Journal Article
American Heart Journal, ISSN 0002-8703, 2016, Volume 174, pp. 95 - 102
Background Proton pump inhibitors (PPIs) are frequently prescribed in combination with clopidogrel, but conflicting data exist as to whether PPIs diminish the... 
Cardiovascular | LANSOPRAZOLE | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | CLOPIDOGREL | CARDIOVASCULAR EVENTS | PREVENTION | OMEPRAZOLE | Follow-Up Studies | Humans | Middle Aged | Male | Aspirin - administration & dosage | Proton Pump Inhibitors - administration & dosage | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Electrocardiography | Ticlopidine - administration & dosage | Female | Hyperplasia - drug therapy | Drug Therapy, Combination | Myocardial Infarction - diagnosis | Myocardial Infarction - surgery | Coronary Vessels - drug effects | Coronary Vessels - pathology | Administration, Oral | Treatment Outcome | Ticlopidine - analogs & derivatives | Hyperplasia - etiology | Hyperplasia - pathology | Tunica Intima - drug effects | Graft Occlusion, Vascular - etiology | Tunica Intima - pathology | Graft Occlusion, Vascular - pathology | Graft Occlusion, Vascular - drug therapy | Coronary Vessels - surgery | Aged | Stents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Transluminal angioplasty | Care and treatment | Cardiac patients | Patient outcomes | Clinical trials | Proton pump inhibitors | Stent (Surgery) | Studies | Consortia | Heart attacks | Coronary vessels | Classification | Prodigies | Metabolism | Multivariate analysis | Stents | Clinical outcomes
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 10/2017, Volume 90, Issue 4, pp. E73 - E84
Objectives To assess whether moderate‐to‐severe CKD is a treatment modifier for benefit or harm in patients randomly allocated to 24‐month versus 6‐month DAPT.... 
clopidogrel | cardiovascular events | bleeding | chronic kidney disease (CKD) | DAPT | RANDOMIZED CONTROLLED-TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | EVENTS | DUAL-ANTIPLATELET THERAPY | RENAL-FUNCTION | INDUCED INTIMAL HYPERPLASIA | CLOPIDOGREL THERAPY | PERCUTANEOUS CORONARY INTERVENTION | IMPLANTATION | DRUG-ELUTING STENTS | Multivariate Analysis | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Male | Renal Insufficiency, Chronic - complications | Coronary Disease - mortality | Time Factors | Coronary Disease - complications | Platelet Aggregation Inhibitors - administration & dosage | Aged, 80 and over | Renal Insufficiency, Chronic - mortality | Female | Renal Insufficiency, Chronic - diagnosis | Drug Therapy, Combination | Myocardial Infarction - etiology | Platelet Aggregation Inhibitors - adverse effects | Severity of Illness Index | Drug Administration Schedule | Risk Factors | Proportional Hazards Models | Treatment Outcome | Coronary Disease - diagnosis | Chi-Square Distribution | Disease-Free Survival | Stroke - etiology | Coronary Disease - therapy | Intention to Treat Analysis | Italy | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects | Stroke (Disease) | Hypertension | Transluminal angioplasty | Care and treatment | Chronic kidney failure | Patient outcomes | Cardiac patients | Coronary heart disease | Myocardial infarction | Surgical implants | Stroke | Decision making | Diabetes mellitus | Coronary artery | Implantation | Cardiovascular disease | Coronary artery disease | Patients | Bleeding | Cerebrovascular system | Implants | Infarction | Kidney diseases | Heart diseases | Stents | Prolongation | Kidney transplantation
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 11, pp. B76 - B76
  Methods Monocentric, prospective, observational registry enrolling patients undergoing coronary angiography with at least one of: age >=75; diabetes; stages... 
Cardiovascular | Internal Medicine | Medical research | Mortality | Heart attacks
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2017, Volume 189, pp. 128 - 136
Journal Article
Journal of Cardiovascular Translational Research, ISSN 1937-5387, 06/2015, Volume 8, Issue 4, pp. 211 - 220
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2015, Volume 212, pp. 110 - 117
Journal Article
Current Cardiology Reports, ISSN 1523-3782, 1/2017, Volume 19, Issue 1, pp. 1 - 10
Journal Article